The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 28, 2023

Filed:

Apr. 27, 2018
Applicants:

Jonathon P. Audia, Mobile, AL (US);

James M. Downey, Mobile, AL (US);

Diego Alvarez, Mobile, AL (US);

Michael V. Cohen, Mobile, AL (US);

Inventors:

Jonathon P. Audia, Mobile, AL (US);

James M. Downey, Mobile, AL (US);

Diego Alvarez, Mobile, AL (US);

Michael V. Cohen, Mobile, AL (US);

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/7076 (2006.01); A61P 9/10 (2006.01); A61K 31/519 (2006.01); A61K 38/55 (2006.01);
U.S. Cl.
CPC ...
A61K 31/7076 (2013.01); A61K 31/519 (2013.01); A61K 38/55 (2013.01); A61P 9/10 (2018.01);
Abstract

The present disclosure generally pertains to methods of treating myocardial infarct involving administering a platelet anti-aggregate, a cysteine-aspartic protease inhibitor, and reperfusion therapy. In certain embodiments, the platelet anti-aggregate is at least one P2Yreceptor antagonist or Glycoprotein IIb/IIIa inhibitor, the cysteine-aspartic protease inhibitor is selected from the group consisting of Caspase-1, 4, 5, 11 and 12 inhibitors, and reperfusion therapy is percutaneous coronary intervention. In certain embodiments, the at least one P2Yreceptor antagonist is selected from the group consisting of cangrelor, ticagrelor, clopidogrel and prasugrel. The disclosed methods provide an improved cardioprotective effect against infarction when compared with the current standard of care.


Find Patent Forward Citations

Loading…